Shanghai Kinetic to acquire Elliquence for $77 M

Shanghai Kinetic Medical Co recently announced that it plans to take over US medical technology company Elliquence LLC for $77.15 million.

Elliquence makes radiofrequency products that are used in minimally invasive orthopedic surgeries, especially for disc herniation and intervertebral disc tear.

About 52 per cent of Elliquence's revenues are from China. Kinetic Medical, which plans to gradually take over distribution of Elliquence's products, also makes minimally invasive surgical systems, especially for orthopedic surgeries, plus orthopedic implants and stents.

Elliquence CEO Alan Ellman will remain responsible for the US and international businesses after the deal.